NEWS   I   CHARITIES   I   CONTACT      

Board of Directors

Board of Directors

Nicole-Formica-Schiller-Pamanicor-AG

Nicole Formica-Schiller

CEO, Founder

“Pamanicor Health AG is the realization of my goals of building an international company based on expertise, values and excellence. Together with our talented team we help simplify the complexity of disruptive technologies and the global digital transformation in health. It is essential that we are at the forefront of the latest developments and open up the dialogue with all stakeholders.” 

  • Author of top pre-order ranked “Künstliche Intelligenz und Blockchain im Gesundheitswesen: Wie COVID-19 und zukunftsweisende Technologien den Status quo revolutionieren“ (for English click here)
  • Preeminent thought-provoking expert in Artificial Intelligence (AI), Blockchain, Disruptive Technologies, Deep Tech, Data, Digital Health and Ethics at the intersection to digital transformation, innovation, and disruption in health
  • Forged an unprecedented path in visualizing future trends, digital transformation and innovation strategies by helping readers humanize the relationship between disruptive innovation and its impact on institutions, markets and societies including Big Tech
  • Sought-after advisor in Digital & Health Policy, Regulatory & External Affairs, Digital Geopolitics and high-level Stakeholder Relations Management on national, EU and global level
  • Selected by Forbes for “best/most exciting/innovative” ideas, to attend “Writing Future Codes” Summit in Zürich Switzerland, sharing her approach on the implications of Artificial Intelligence
  • Featured in the media, e.g. Breakingthrough and Lawyers Magazine as role model for entrepreneurial and digital thinking
  • Contributor to Commissions, Boards globally, e.g. Data Ethics Commission German Government, Crypto Valley Blockchain Association, former Vice President HBA Healthcare Businesswomen Association (world biggest nonprofit association for gender diversity in healthcare) Zürich Switzerland
  • Board member German AI Association, KI Bundesverband (Germany’s largest AI Association) and Spokesperson Media & Public (Bavaria), Advisor Task Force “Regulatory & AI” and “Health & AI”
  • Co-Author “EU Regulation of AI” position paper by German AI Association
  • Highly sought-after international speaker and panelist (e.g. Davos Digital Forum Health Switzerland | Australian Gov. Trade & Investment AI Bootcamp | GAWBL-Summit UAE, Germany | Ministry of Economics Baden-Württemberg, Digitalgipfel, Germany (postponed Covid-19) | Deloitte Health Connect Series
  • Initiator and project lead for “Blockchain and AI: A new paradigm shift in biopharmaceutical financing and R&D” at Center for Entrepreneurial and Financial Studies (Prof. Ann-Kristin Achleitner etc.) of Technical University Munich (TUM)/Germany
  • Former Liaison Officer for the CEO of Nord Stream, chaired by Germany’s ex-chancellor G. Schröder, and Task Force member playing integral role in managing Europe’s largest public consultation and stakeholder management process
  • Before founding Pamanicor Health AG held various global roles of increasing responsibility working across Europe, Asia, Russia and Switzerland, e.g., Freshfields Bruckhaus Deringer, Shearman Sterling, Allianz AG and Munich RE
  • Graduated from top-ranked Ludwig-Maximilians-University Munich, Germany, as Attorney-at-Law and University of Bayreuth with additional business degree.
mel-formica

Mel Formica, PhD, MBA

Member of the Board

“Pamanicor Health AG, enables me to not only advise our international clients on their business challenges. It also provides me with the opportunity to help them understand the fast-changing Life Sciences and Biopharmaceuticals world including new advanced therapies and therefore, partner with them to create sustainable business transformations that benefit patients all over the globe.”

  • 20+ years of experience in leadership roles spanning clinical research, marketing, strategic consulting and value and evidence generation
  • Successful global blockbuster biopharmaceutical product launches
  • International expert in integrating novel evidence-based methods to drive efficiencies in medical and commercial data generation, data synthesis and data utilization
  • Transformation leader who has pioneered new organizational models leading to improved operating efficiency and driving business growth
  • Leadership roles at major biopharmaceutical companies including Takeda Pharmaceuticals International, Amgen Inc., Abbott Laboratories working in Australia, U.S., China, Japan, Switzerland and Europe
  • Academic and research appointments as Assistant Professor at the College of Physicians and Surgeons of Columbia University, New York, St. Luke’s-Roosevelt Hospital Center, New York and Helen Hayes Hospital, New York